Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

SCHERING-PLOUGH

(SGP)
SummaryNewsCompany 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

SCHERING-PLOUGH : Brooke Shields and the Makers of COPPERTONE(R) Join Together to Launch COPPERTONE(R) NutraShield(TM) - New Sunscreen Contains Antioxidants That Promote Natural Skin Repair

01/27/2009 | 10:00am EST

Dual Defense(TM) Technology Latest Innovation from COPPERTONE(R) Solar Research Center

KENILWORTH, N.J., Jan. 27 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP), the makers of COPPERTONE(R), announced today that actress and model Brooke Shields will become the spokesperson for the brand's new beauty line, COPPERTONE(R) NutraShield(TM) with Dual Defense(TM) - a broad spectrum sunscreen lotion enriched with antioxidants that promote natural skin repair and combat premature skin aging from the sun.

(Photo: http://www.newscom.com/cgi-bin/prnh/20090127/NY62932)

An international beauty icon, Ms. Shields stays current on the latest trends in maintaining optimal skin health and understands how year-round sun exposure can slowly deplete unprotected skin of its radiance over time. "I am excited to work with the COPPERTONE brand to help raise awareness on the need for year-round sun protection and the benefits of antioxidants in promoting natural skin repair," Shields said.

COPPERTONE(R) Adds Antioxidants to Help Replenish Skin

The COPPERTONE NutraShield product line - the latest innovation from the COPPERTONE Solar Research Center - evolves the brand beyond its suncare roots to a new level of antioxidant-enhanced suncare. The power of NutraShield lies in its Dual Defense technology, combining a broad spectrum sunscreen, to protect against UVA and UVB rays, and antioxidants to replenish skin, supporting its natural repair process.

"The changing environment is altering the way people think about the sun's effects on skin. Our research indicates that consumers want not only broad spectrum sunscreens with higher sun protection factors (SPFs) to help prevent sun damage, but also formulas with antioxidants that can help promote natural skin repair," said Patricia Agin, Ph.D., fellow in skincare research and development at the COPPERTONE Solar Research Center. "Our legacy of continuous innovation led to the development of COPPERTONE NutraShield and its Dual Defense technology, providing women an affordable skin-care option that delivers a high level of sun protection as well as antioxidants to help nourish skin."

The COPPERTONE NutraShield line includes a SPF 70+ Faces lotion as well as SPF 70+ and SPF 30 lotions for the body. The product line is available online and at mass retailers across the country.

About COPPERTONE

COPPERTONE, Water BABIES, COPPERTONE SPORT, ultraGUARD and COPPERTONE KIDS are registered trademarks and NutraShield and Dual Defense are trademarks of Schering-Plough HealthCare Products, Inc.

About Schering-Plough

Schering-Plough Consumer Health Care is the U.S. over-the-counter (OTC) and consumer products business unit of Schering-Plough, an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world. The company applies its research-and-development platform to human prescription, animal health and consumer health care products. Schering-Plough's vision is to "Earn Trust, Every Day" with the doctors, patients, customers and other stakeholders served by its colleagues around the world. The company is based in Kenilworth, N.J., and its Web site is www.schering-plough.com.

SCHERING-PLOUGH DISCLOSURE NOTICE:

The information in this press release includes certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including statements relating to potential market for COPPERTONE(R) NUTRASHIELD(TM). Forward-looking statements relate to expectations or forecasts of future events. Schering-Plough does not assume the obligation to update any forward-looking statement. Many factors could cause actual results to differ materially from Schering-Plough's forward-looking statements, including market forces, economic factors, product availability, patent and other intellectual property protection, current and future branded, generic or over-the-counter competition, the regulatory process, and any developments following regulatory approval, among other uncertainties. For further details about these and other factors that may impact the forward-looking statements, see Schering-Plough's Securities and Exchange Commission filings, including Part II, Item 1A. "Risk Factors" in the third quarter 2008 10-Q, filed October 29, 2008.

SOURCE Schering-Plough Corporation


ę PRNewswire 2009
All news about SCHERING-PLOUGH
2009SCHERING-PLOUGH : Announces Sponsorship of Rabies-Control Projects in India
PR
2009SCHERING-PLOUGH : Investigational Sublingual Allergy Immunotherapy Tablet Meets Primary En..
PR
2009SCHERING-PLOUGH : U.S. Food and Drug Administration Issues Complete Response Letter Regard..
PR
2009SCHERING-PLOUGH : Standard & Poor's Announces Changes to U.S. Indices
PR
2009SCHERING-PLOUGH : Reports Financial Results for 2009 Third Quarter
PR
2009SCHERING-PLOUGH : Nobilon Advances Intranasal Seasonal Influenza Vaccine Into Proof of Con..
PR
2009SCHERING-PLOUGH : Schedules Conference Call Webcast For 2009 Third Quarter Earnings
PR
2009SCHERING-PLOUGH : SIMPONI(TM) (golimumab) Receives European Approval as Once-Monthly Subcu..
PR
2009SCHERING-PLOUGH : Declares Quarterly Dividends on Common Shares and Mandatory Convertible ..
PR
2009SCHERING-PLOUGH : Reports Long-Term Vicriviroc Data From Phase II Open-Label Extension Stu..
PR
More news